212 related articles for article (PubMed ID: 15281910)
1. Proteomic analysis for the assessment of diabetic renal damage in humans.
Mischak H; Kaiser T; Walden M; Hillmann M; Wittke S; Herrmann A; Knueppel S; Haller H; Fliser D
Clin Sci (Lond); 2004 Nov; 107(5):485-95. PubMed ID: 15281910
[TBL] [Abstract][Full Text] [Related]
2. Impact of diabetic nephropathy and angiotensin II receptor blockade on urinary polypeptide patterns.
Rossing K; Mischak H; Parving HH; Christensen PK; Walden M; Hillmann M; Kaiser T
Kidney Int; 2005 Jul; 68(1):193-205. PubMed ID: 15954909
[TBL] [Abstract][Full Text] [Related]
3. Identification of urinary protein pattern in type 1 diabetic adolescents with early diabetic nephropathy by a novel combined proteome analysis.
Meier M; Kaiser T; Herrmann A; Knueppel S; Hillmann M; Koester P; Danne T; Haller H; Fliser D; Mischak H
J Diabetes Complications; 2005; 19(4):223-32. PubMed ID: 15993357
[TBL] [Abstract][Full Text] [Related]
4. Proteomic identification of urinary biomarkers of diabetic nephropathy.
Rao PV; Lu X; Standley M; Pattee P; Neelima G; Girisesh G; Dakshinamurthy KV; Roberts CT; Nagalla SR
Diabetes Care; 2007 Mar; 30(3):629-37. PubMed ID: 17327332
[TBL] [Abstract][Full Text] [Related]
5. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
[TBL] [Abstract][Full Text] [Related]
6. Electrophoretic methods for analysis of urinary polypeptides in IgA-associated renal diseases.
Julian BA; Wittke S; Novak J; Good DM; Coon JJ; Kellmann M; Zürbig P; Schiffer E; Haubitz M; Moldoveanu Z; Calcatera SM; Wyatt RJ; Sýkora J; Sládková E; Hes O; Mischak H; McGuire BM
Electrophoresis; 2007 Dec; 28(23):4469-83. PubMed ID: 18004714
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of urine proteome pattern analysis for its potential to reflect coronary artery atherosclerosis in symptomatic patients.
von Zur Muhlen C; Schiffer E; Zuerbig P; Kellmann M; Brasse M; Meert N; Vanholder RC; Dominiczak AF; Chen YC; Mischak H; Bode C; Peter K
J Proteome Res; 2009 Jan; 8(1):335-45. PubMed ID: 19053529
[TBL] [Abstract][Full Text] [Related]
8. Pilot study of capillary electrophoresis coupled to mass spectrometry as a tool to define potential prostate cancer biomarkers in urine.
Theodorescu D; Fliser D; Wittke S; Mischak H; Krebs R; Walden M; Ross M; Eltze E; Bettendorf O; Wulfing C; Semjonow A
Electrophoresis; 2005 Jul; 26(14):2797-808. PubMed ID: 15981297
[TBL] [Abstract][Full Text] [Related]
9. Urinary excretions of lipocalin-type prostaglandin D synthase predict renal injury in type-2 diabetes: a cross-sectional and prospective multicentre study.
Uehara Y; Makino H; Seiki K; Urade Y;
Nephrol Dial Transplant; 2009 Feb; 24(2):475-82. PubMed ID: 18799608
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis of urinary protein markers for accurate prediction of diabetic kidney disorder.
Jain S; Rajput A; Kumar Y; Uppuluri N; Arvind AS; Tatu U
J Assoc Physicians India; 2005 Jun; 53():513-20. PubMed ID: 16121805
[TBL] [Abstract][Full Text] [Related]
11. Urinary tumour necrosis factor-alpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients.
Navarro JF; Mora C; Muros M; García J
Nephrol Dial Transplant; 2006 Dec; 21(12):3428-34. PubMed ID: 16935891
[TBL] [Abstract][Full Text] [Related]
12. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
de Zeeuw D
Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
[TBL] [Abstract][Full Text] [Related]
13. Quantitative urinary proteome analysis for biomarker evaluation in chronic kidney disease.
Jantos-Siwy J; Schiffer E; Brand K; Schumann G; Rossing K; Delles C; Mischak H; Metzger J
J Proteome Res; 2009 Jan; 8(1):268-81. PubMed ID: 19012428
[TBL] [Abstract][Full Text] [Related]
14. Effect of high dose thiamine on the levels of urinary protein biomarkers in diabetes mellitus type 2.
Riaz S; Skinner V; Srai SK
J Pharm Biomed Anal; 2011 Mar; 54(4):817-25. PubMed ID: 21130593
[TBL] [Abstract][Full Text] [Related]
15. [The significance of determination of urinary type IV collagen concentrations from a random urine collection in patients with non-insulin dependent diabetes mellitus].
Kotajima N; Fukumura Y; Obata K; Kobayashi I
Rinsho Byori; 1998 Mar; 46(3):277-82. PubMed ID: 9564768
[TBL] [Abstract][Full Text] [Related]
16. Urinary activities of cathepsin B, N-acetyl-beta-D-glucosaminidase, and albuminuria in patients with type 2 diabetes mellitus.
Piwowar A; Knapik-Kordecka M; Fus I; Warwas M
Med Sci Monit; 2006 May; 12(5):CR210-4. PubMed ID: 16641878
[TBL] [Abstract][Full Text] [Related]
17. High resolution proteome/peptidome analysis of body fluids by capillary electrophoresis coupled with MS.
Schiffer E; Mischak H; Novak J
Proteomics; 2006 Oct; 6(20):5615-27. PubMed ID: 16991199
[TBL] [Abstract][Full Text] [Related]
18. Effects of aerobic exercise on microalbuminuria and enzymuria in type 2 diabetic patients.
Lazarevic G; Antic S; Vlahovic P; Djordjevic V; Zvezdanovic L; Stefanovic V
Ren Fail; 2007; 29(2):199-205. PubMed ID: 17365936
[TBL] [Abstract][Full Text] [Related]
19. Study of urinary 8-hydroxydeoxyguanosine as a biomarker of oxidative DNA damage in diabetic nephropathy patients.
Xu GW; Yao QH; Weng QF; Su BL; Zhang X; Xiong JH
J Pharm Biomed Anal; 2004 Sep; 36(1):101-4. PubMed ID: 15351053
[TBL] [Abstract][Full Text] [Related]
20. Utility of Albusure test in screening for early stage of diabetic nephropathy.
Zhang J; Lnoue K; Nakashima N; Hiramatsu S; Ohashi M; Umeda F; Nawata H
Chin Med J (Engl); 1994 Sep; 107(9):699-702. PubMed ID: 7805464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
